I. -L. Shih

I. -L. Shih

Auto-generated profile, based on publicly available information

I. -L. Shih

Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2019 in Liver Cancer
Verified
Journal Article
Open access
PDF file
LLLi-Chun Lu
Li-Chun Lu
CHChiun Hsu
Chiun Hsu
YSYu-Yun Shao
Yu-Yun Shao
YCYee Chao
Yee Chao
CYChia-Jui Yen
Chia-Jui Yen
LCLi-Tzong Chen
Li-Tzong Chen
Background and Aims: Immune checkpoint inhibitors (ICIs) exhibit significant clinical activity in patients with advanced hepatocellular carcinoma (HCC). This study explored whether tumor response to ICIs in HCC varies among different organs. Methods: We reviewed the data of patients with advanced HCC who had received ICIs. Patients with measurable diseases were enrolled. Organ-specific response criteria, adapted from RECIST 1.1 and immune-related RECIST, were used to evaluate the objective response to ICIs in tumors located in the liver, lung, lymph node, and other intra-abdominal sites. Results: Of the 75 enrolled patients with advanced HCC, 51 and 11 patients had chronic hepatitis B virus and chronic hepatitis C virus infection, respectively. Regarding ICI treatment, 58, 1, and 16 patients had undergone anti-PD-1/anti-PD-L1 monoclonal antibody (mAb) alone, anti-CTLA4 mAb alone, and anti-PD-1 mAb plus anti-CTLA4 mAb, respectively; 20 and 55 patients had received ICIs as first-line or ≥second-line therapy. The overall objective response rate (ORR) was 28.0%. In total, 58, 34, 19, and 18 patients had measurable hepatic tumors and lung, lymph node, and other intra-abdominal metastases, and the corresponding organ-specific ORRs were 22.4, 41.2, 26.3, and 38.9%, respectively. Of the 39 patients who had both hepatic and extrahepatic tumors, 12 had disease control in extrahepatic tumors while progressive disease (PD) in hepatic tumors, whereas only 4 exhibited disease control in hepatic tumors while PD in extrahepatic tumors (p = 0.046, McNemar test). Of the 16 patients with only evaluable tumors in the liver and lungs at baseline, 8 had disease control in the lungs while PD in the liver, and none experienced disease control in the liver while PD in the lungs (p = 0.005). Conclusions: The hepatic tumors of HCC may be less responsive to ICIs than extrahepatic lesions. Lung metastases responded most favorably to ICIs. The mechanisms underlying this differential response to ICIs warrant further investigation.

19 March 2016 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
BANG-BIN CHENBANG-BIN CHEN
BANG-BIN CHEN
YTYu-Wen Tien
Yu-Wen Tien
MCMing-Chu Chang
Ming-Chu Chang
MCMEI-FANG CHENG
MEI-FANG CHENG
YCYu-Ting Chang
Yu-Ting Chang
TSTiffany Ting-Fang Shih
Tiffany Ting-Fang Shih

27 April 2015 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
ISI‐Lun Shih
I‐Lun Shih
RYRuoh-Fang Yen
Ruoh-Fang Yen
CCChi-An Chen
Chi-An Chen
BANG-BIN CHENBANG-BIN CHEN
BANG-BIN CHEN
SWShwu‐Yuan Wei
Shwu‐Yuan Wei
TSTiffany Ting-Fang Shih
Tiffany Ting-Fang Shih

1 January 2017 in Intestinal Research
Verified
Journal Article
Open access
PDF file
SWShu-Chen Wei
Shu-Chen Wei
TCTing-An Chang
Ting-An Chang
TCTe-Hsin Chao
Te-Hsin Chao
JCJinn-Shiun Chen
Jinn-Shiun Chen
JCJen-Wei Chou
Jen-Wei Chou
JWJau-Min Wong
Jau-Min Wong
Wei SC, et al. Intest Res. 2017 Jul;15(3):266-284. https://doi.org/10.5217/ir.2017.15.3.266

1 January 2017 in Intestinal Research
Verified
Journal Article
Open access
PDF file
SWShu-Chen Wei
Shu-Chen Wei
TCTing-An Chang
Ting-An Chang
TCTe-Hsin Chao
Te-Hsin Chao
JCJinn-Shiun Chen
Jinn-Shiun Chen
JCJen-Wei Chou
Jen-Wei Chou
JWJau-Min Wong
Jau-Min Wong
Wei SC, et al. Intest Res. 2017 Jul;15(3):285-310. https://doi.org/10.5217/ir.2017.15.3.285

23 February 2018 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
BANG-BIN CHENBANG-BIN CHEN
BANG-BIN CHEN
YTYu-Wen Tien
Yu-Wen Tien
MCMing-Chu Chang
Ming-Chu Chang
MCMEI-FANG CHENG
MEI-FANG CHENG
YCYu-Ting Chang
Yu-Ting Chang
TSTiffany Ting-Fang Shih
Tiffany Ting-Fang Shih